Cargando…
Adequate antibody response to BioNTech COVID vaccine in a multiple sclerosis patient treated with siponimod
Autores principales: | Siddiqui, Gulnaz, Maloni, Heidi, Nava, Victor E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669414/ https://www.ncbi.nlm.nih.gov/pubmed/34924749 http://dx.doi.org/10.1186/s41983-021-00428-8 |
Ejemplares similares
-
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
por: Havla, Joachim, et al.
Publicado: (2021) -
Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023) -
Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023) -
Cutaneous reactions after CoronaVac and BioNTech vaccines
por: Öner, Ümran, et al.
Publicado: (2022) -
Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)